Tuesday, November 17, 2015

Breast cancer drug is too expensive for the NHS, watchdog rules

… from an aggressive form of breast cancer extra months of life – was … .  It is licensed for HER2-positive breast cancer and has been shown to … treating some patients with advanced breast cancer. However, the price that the … of policy and campaigns at Breast Cancer Now, said it was “hugely …

No comments:

Post a Comment